Morrison Foerster expands with trio of litigators

The firm adds three partners to its New York office | Expansion brings a combined 60 years of experience | Hires experienced in high-stakes patent disputes involving biologics, small-molecule drugs, and medical devices.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Hogan Lovells and Cadwalader strike historic deal to create $3.6bn firm

22 December 2025 Global law firm and Wall Street institution to join forces, forming one of the world’s five largest law firms by revenue and significantly expanding global and US market reach.

Careers

Morgan Lewis continues coast-to-coast US expansion with life sciences specialist

17 December 2025 The firm’s new hire is known for advising Boston’s biotech, pharmaceutical and chemical companies on patent strategies and commercialising scientific inventions.

Careers

Winston & Strawn and Taylor Wessing UK plan transatlantic combo

15 December 2025 The proposed 1,400-strong firm will combine Taylor Wessing's top UK and European practice with Winston & Strawn's US-focused IP litigation team.

More features

UPC: A review of 2025 and what to expect in 2026

Mental health in IP: ‘We have a clear picture of the problem’

From Edwards to Insulet: Three key medical device cases of 2025

Edwards v Meril: Behind the UPC’s landmark medtech showdown

5 ways the USPTO director is changing US innovation

EU unveils sweeping pharma, biotech, and medical device reforms

Mirum targets generics in quartet of suits over liver treatment

Hogan Lovells and Cadwalader strike historic deal to create $3.6bn firm

Morrison Foerster expands with trio of litigators

More on this story

Editor's picks

Editor's picks

More features